|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: June 2024
Volume 9 | Issue 6
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 97
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Review: Revolutionizing Drug Delivery And Cancer Therapeutics Through Niosome Innovation |
| Authors Name: | Miss.Gore Rushali J. , Prof.Waghmare S.U , Prof.Akolkar P.B , Miss.Chavan Anushka M. , Miss.Hiwarde Dipali B. |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_224054
|
| Published Paper Id: | IJNRDTH00173 |
| Published In: | Volume 9 Issue 6, June-2024 |
| DOI: | |
| Abstract: | Niosomes are vesicular nanocarriers, biodegradable, relatively non-toxic, stable, and inexpensive, that provide an alternative for lipid-solid carriers, niosomes similar to liposomes, can tackle challenges associated with instability, rapid degradation, bioavailability, and insolubility of various drugs or natural compounds. Niosomes are highly efficient systems for the targeted delivery of anticancer, antioxidant, anti-inflammatory, antimicrobial, and antibacterial agents. This review aims to provide an overview of their composition, the most common formulation techniques, and recent applications as delivery systems in cancer therapy. Cancer remains a major health concern worldwide, and the need for effective treatment options is crucial. Drug delivery systems, such as niosomes, have shown promise in improving cancer treatment outcomes by enhancing drug delivery efficiency. This review explores the role of niosomes in cancer treatment and how they can improve outcomes through efficient drug delivery. The method, results, Discussion, and conclusion will be discussed in detail Recently, nanotechnology is involved in various feilds of science, of which medicine is one of the most obvious. Nanoparticles have revolutionized the field of disease treatment and diagnosis, offering novel therapeutic strategies with efficient mechanisms of action. Personalized medicine aims to minimize treatment side effects and provide targeted therapies. Therefore, targeted drug delivery is crucial, particularly for patients on combination therapies, as different drug structures often require distinct delivery systems to maintain efficacy. Niosomes, a type of polymeric nanoparticle, have shown promise in drug delivery due to their favorable characteristics. These include biocompatibility, high absorption, reduced drug dosage requirements, and the ability to target drug release. Moreover, Niosome vesicles can encapsulate both hydrophilic and lipophilic drugs, enhancing the versatility and effectiveness of treatment. Various factors, such as components, preparation methods, and optimization techniques, affect the size and formation of niosomal structures. In this review, we first examined the characteristics of niosome vesicles and then explained the in silico tools used for designing, predicting, and optimizing them. We also compared and discussed anticancer drugs delivered by niosomes, highlighting their potential as a model for designing therapeutic strategies. This research aimed to explore all aspects of drug delivery engineering using niosomes, and we presented clinical examples of these nanocarriers in cancer treatment to illustrate their clinical benefits. |
| Keywords: | Keywords: Cancer, Niosomes, Structure, Drug delivery, Treatment outcomes, Nanocarrier, Formulation techniques; Cancer therapy; Delivery systems. |
| Cite Article: | "Review: Revolutionizing Drug Delivery And Cancer Therapeutics Through Niosome Innovation", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 6, page no.162-208, June-2024, Available :http://www.ijnrd.org/papers/IJNRDTH00173.pdf |
| Downloads: | 00043 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRDTH00173 Registration ID: 224054 Published In: Volume 9 Issue 6, June-2024 DOI (Digital Object Identifier): Page No: 162-208 Country: Chh.sambhajinagar, Maharashtra , India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRDTH00173 Published Paper PDF: https://www.ijnrd.org/papers/IJNRDTH00173 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn